β blockers in patients with heart failure and atrial fibrillation - Authors' reply

Affiliations

¹ University of Birmingham Centre for Cardiovascular Sciences, Birmingham, UK; Centre of Cardiovascular Research and Education in Therapeutics, Monash University, Melbourne, Australia. Electronic address: d.kotecha@bham.ac.uk.
² Centre for Statistics in Medicine, University of Oxford, Oxford, UK.
³ Internal Medicine Department, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Madrid, Spain.
⁴ Norwich Medical School, University of East Anglia, Norwich, UK.

Comment

Dipak Kotecha et al. Lancet. 2015.

. 2015 Apr 25;385(9978):1618-9.

doi: 10.1016/S0140-6736(15)60789-9.

¹ University of Birmingham Centre for Cardiovascular Sciences, Birmingham, UK; Centre of Cardiovascular Research and Education in Therapeutics, Monash University, Melbourne, Australia. Electronic address: d.kotecha@bham.ac.uk.
² Centre for Statistics in Medicine, University of Oxford, Oxford, UK.
³ Internal Medicine Department, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Madrid, Spain.
⁴ Norwich Medical School, University of East Anglia, Norwich, UK.

No abstract available

Comment on

Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.
Kotecha D, Holmes J, Krum H, Altman DG, Manzano L, Cleland JG, Lip GY, Coats AJ, Andersson B, Kirchhof P, von Lueder TG, Wedel H, Rosano G, Shibata MC, Rigby A, Flather MD; Beta-Blockers in Heart Failure Collaborative Group. Kotecha D, et al. Lancet. 2014 Dec 20;384(9961):2235-43. doi: 10.1016/S0140-6736(14)61373-8. Epub 2014 Sep 2. Lancet. 2014. PMID: 25193873
β blockers in patients with heart failure and atrial fibrillation.
Pérez-Calvo JI, Sánchez-Marteles M, Morales-Rull JL. Pérez-Calvo JI, et al. Lancet. 2015 Apr 25;385(9978):1617-8. doi: 10.1016/S0140-6736(15)60787-5. Lancet. 2015. PMID: 25943811 No abstract available.
β blockers in patients with heart failure and atrial fibrillation.
Shah R. Shah R. Lancet. 2015 Apr 25;385(9978):1618. doi: 10.1016/S0140-6736(15)60788-7. Lancet. 2015. PMID: 25943813 No abstract available.